Tagged: edc
8 results
Jacob Knudsen
Jacob Knudsen is the Chief Marketing Officer of Blade HQ, the Lehi, Utah knife and everyday-carry retailer that has grown from a 2003 startup into one of the largest online cutlery stores in the United States. An industrial designer by training - he earned a BFA from Brigham Young University - Knudsen joined Blade HQ in the mid-2000s and spent roughly sixteen years as its Chief Creative Officer before moving into the CMO seat in 2023. His fingerprints are on the brand's design language and on the content engine behind a YouTube channel with more than half a million subscribers. He is also a serious balisong collector, a subject he walked viewers through on Blade HQ's Collector's Corner, and a co-host of the first episode of the company's Steel and Stories podcast.
Blade HQ
Blade HQ is an online and brick-and-mortar knife retailer founded in 2003, offering thousands of pocket knives, tactical and outdoor blades, multitools, flashlights, and everyday-carry (EDC) gear from top brands like Benchmade, Spyderco, CRKT, Kershaw, and Microtech. Based in Utah with a second location in Marion, Virginia, the company is known for its enormous in-stock selection, Blade HQ Exclusives (limited-edition and collaboration knives made only for its customers), the Blade Club rewards program, and its long-running Knife Life content and video channels that have helped grow the modern EDC community.
Castor
Castor is a health-technology company that builds a cloud-based eClinical platform for running clinical trials - from electronic data capture (EDC) and eConsent to eCOA/ePRO and real-world evidence. Founded in 2012 in Amsterdam by physician-researcher Dr. Derk Arts, Castor set out to replace clunky, expensive trial software with a self-service, researcher-friendly system. Today it supports more than 15,000 studies across 90+ countries and is used by leading CROs and biopharma companies, while pushing decentralized trials and practical AI (Castor Catalyst, built with Google Cloud) into mainstream research.
ClinCapture
ClinCapture is an eClinical software company that builds cloud-based tools for running clinical trials - electronic data capture (EDC), ePRO/eCOA, eConsent, randomization, medical coding, and trial master file management. Born from consulting firm Clinovo and once known as the only free, fully validated open-source EDC in the world, it now markets a unified, AI-augmented platform called Captivate that lets sponsors and CROs design, launch, and manage studies from a single validated cloud system.
Scott Weidley
Scott Weidley is President, CEO and Chief Engineer of ClinCapture, the Las Vegas eClinical company that built its reputation on giving away validated electronic data capture software for free. With two decades in cloud and clinical software, Weidley has steered ClinCapture's Captivate platform toward AI baked into the structural layer of trial design, championed a low-and-no-cost access program called Weidley's Wish, and reinvented himself as a podcaster whose show 'Vibe with Scott Weidley' broadcasts from Vegas and has crossed three million YouTube views.
Curebase
Curebase is a San Francisco-based eClinical software company building an AI-powered platform that runs clinical trials around patients' lives instead of inside hospital walls. Its single system spans study startup to database lock - combining electronic data capture (EDC), eConsent, ePRO/eCOA, patient recruitment, and a virtual research site model - so sponsors can launch decentralized and hybrid trials faster, capture cleaner data, and reach more diverse participant populations.
Medrio
Medrio is a San Francisco-based eClinical software company that helps pharma, biotech, medtech and diagnostics teams run clinical trials with a no-code, cloud-based EDC, eCOA/ePRO, eConsent and RTSM suite. Founded in 2005 and bootstrapped for more than a decade before taking outside capital, Medrio now powers thousands of studies across four continents.
Tom Lemberg
Tom Lemberg is the Founder & CEO of Curebase, a San Francisco-based decentralized clinical trial platform that has enrolled over 60,000 patients across 60+ studies. A Harvard-trained computer scientist and molecular biologist, Lemberg built Curebase from his couch in 2017, joined Y Combinator in 2018, and raised $59M to transform how clinical trials work - letting patients participate from home and bringing their own doctors into the research process. Named to Forbes 30 Under 30 in 2022, he's on a mission to make clinical trials accessible to any patient, anywhere.